NCT00263705View on ClinicalTrials.gov

Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Elderly PatientsBreast Cancer
Interventions
DRUG

Adjuvant capecitabine

Capecitabine 2000 mg/m² daily six cycles

DRUG

capecitabine in aduvant setting

capecitabine in aduvant setting in ederly with breast cancer

Trial Locations (1)

1000

Jules Bordet Institute, Brussels

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER

NCT00263705 - Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study | Biotech Hunter | Biotech Hunter